This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Problems related to physical environment
Z21_PROBL_RELATED_PHYSIC_ENVIRONMENT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
295 |
4. Check minimum number of eventsNone |
295 |
5. Include endpointsNone |
295 |
6. Filter based on genotype QC (FinnGen only) |
286 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z5[5-9]|Z6
Similar endpoints
↥List of similar endpoints to
Problems related to physical environment
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to socioeconomic and psychosocial circumstances
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 286 | 219 | 67 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.03 |
| Median age at first event (years) | 44.63 | 43.42 | 48.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 295
- Matched controls
- 2950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z58.8
ICD-10 Finland
Other problems related to physical environment
+∞
292.8
230
*
XQ800
NOMESCO Finland
Prick test
11.2
77.3
99
127
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
15.0
73.3
72
62
J45.0
ICD-10 Finland
Predominantly allergic asthma
8.2
56.0
91
152
J45.1
ICD-10 Finland
Nonallergic asthma
9.2
54.5
77
109
J31.0
ICD-10 Finland
Chronic rhinitis
8.2
53.5
85
138
R03DC03
ATC
montelukast; oral
4.8
35.8
111
327
Z2221
NOMESCO Finland
Medical doctor
4.4
35.4
148
547
Z58.1
ICD-10 Finland
Exposure to air pollution
197.7
34.5
35
*
Z3231
NOMESCO Finland
Registered nurse
4.2
32.1
142
539
J45.9
ICD-10 Finland
Asthma, unspecified
4.3
30.5
111
364
R03BA02
ATC
budesonide; inhalant
4.3
30.0
110
362
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
7.2
29.3
48
78
R03AC02
ATC
salbutamol; inhalant
4.7
28.0
234
1333
R4110
NOMESCO Finland
Physiotherapy
3.7
27.1
134
537
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.0
26.7
106
366
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
23.8
78
233
R03BA05
ATC
fluticasone; inhalant
3.6
23.0
102
374
J30.3
ICD-10 Finland
Other allergic rhinitis
6.7
22.8
39
66
J45
ICD-10 Finland
Asthma
4.5
22.4
63
167
Z3226
NOMESCO Finland
Physiotherapist
3.6
21.2
92
331
ZXD10
NOMESCO Finland
Scheduled procedure
3.2
21.0
155
766
R03BB04
ATC
tiotropium bromide; inhalant
4.8
20.6
52
126
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.8
20.2
77
253
T78.4
ICD-10 Finland
Allergy, unspecified
6.3
19.5
35
62
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
6.8
18.9
31
50
S01GX01
ATC
cromoglicic acid; ophthalmic
3.2
18.9
106
443
R01AD08
ATC
fluticasone; nasal
2.9
17.9
130
624
R06AX27
ATC
desloratadine; oral
2.9
17.9
132
639
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
7.6
17.7
26
37
H02AB07
ATC
prednisone; oral
3.6
17.4
70
237
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
16.4
34
69
R06AX22
ATC
ebastine; oral
3.0
15.3
89
374
R03AK07
ATC
formoterol and budesonide; inhalant
2.9
14.9
96
426
Z58.0
ICD-10 Finland
Exposure to noise
+∞
14.7
14
*
R01AD09
ATC
mometasone; nasal
2.6
14.3
181
1113
ZXE00
NOMESCO Finland
One hour or less
2.6
14.2
145
805
R01AD05
ATC
budesonide; nasal
3.9
14.1
46
134
EB1AA, ,
SPAT
4.2
14.1
41
110
R03BA01
ATC
beclometasone; inhalant
3.2
14.0
68
256
R03BB01
ATC
ipratropium bromide; inhalant
5.8
13.8
26
48
C01CA24
ATC
epinephrine; parenteral
4.0
13.7
43
122
Z58.9
ICD-10 Finland
Problem related to physical environment, unspecified
+∞
13.6
13
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.8
13.4
45
134
R05
ICD-10 Finland
Cough
2.7
13.2
91
415
J45.8
ICD-10 Finland
Mixed asthma
6.2
12.9
23
40
R03DA04
ATC
theophylline; systemic, rectal
5.3
12.9
27
55
R06.2
ICD-10 Finland
Wheezing
5.1
12.6
28
60
R06AE07
ATC
cetirizine; oral
2.4
12.6
163
994
Z71.8
ICD-10 Finland
Other specified counselling
2.5
12.2
116
614
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.8
11.9
39
114
ZXD20
NOMESCO Finland
Day surgery
3.1
11.8
56
207
R03AC03
ATC
terbutaline; inhalant
2.9
11.5
63
252
H10.4
ICD-10 Finland
Chronic conjunctivitis
14.7
11.1
18
13
R06AX26
ATC
fexofenadine; oral
3.4
10.3
39
125
R06.0
ICD-10 Finland
Dyspnoea
2.4
10.2
93
477
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
4.5
10.1
25
59
J01FA10
ATC
azithromycin; systemic
2.3
10.0
208
1492
D01
ICPC
Abdominal pain/cramps general
3.0
9.8
49
186
Z2446
NOMESCO Finland
Social worker
3.6
9.8
34
103
R96
ICPC
Asthma
3.2
9.6
42
147
ZXA10
NOMESCO Finland
Bilateral
2.6
9.5
65
291
A02BC05
ATC
esomeprazole; systemic
2.1
9.4
142
890
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
9.2
55
229
R06AX13
ATC
loratadine; oral
2.5
9.2
66
301
R03BC03
ATC
nedocromil; inhalant
3.4
9.1
35
113
R03AC13
ATC
formoterol; inhalant
3.8
9.0
29
83
R03BA08
ATC
ciclesonide; inhalant
2.9
8.9
45
171
R07.0
ICD-10 Finland
Pain in throat
3.4
8.9
33
104
H02AB06
ATC
prednisolone; systemic
2.1
8.9
159
1054
N06AB04
ATC
citalopram; systemic
2.3
8.8
81
413
R49.01
ICD-10 Finland
Functional dysphonia
4.4
8.6
22
53
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.8
8.6
49
199
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
8.5
101
572
R02
ICPC
Shortness of breath/dyspnoea
2.7
8.3
48
196
J01FA09
ATC
clarithromycin; systemic
2.1
8.3
121
739
J01FA06
ATC
roxithromycin; oral
2.0
8.1
140
909
ZXA00
NOMESCO Finland
Right side
2.2
8.1
86
465
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.0
8.0
37
134
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
7.8
71
360
R03AK08
ATC
formoterol and beclometasone; inhalant
4.0
7.7
22
58
R01BA52
ATC
pseudoephedrine, combinations; oral
2.0
7.6
116
717
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
82.1
7.5
8
*
J02AC01
ATC
fluconazole; systemic
2.0
7.4
149
1009
A07AA02
ATC
nystatin; oral
3.5
7.4
26
79
R03AC12
ATC
salmeterol; inhalant
4.0
7.4
21
55
J01AA02
ATC
doxycycline; systemic
2.4
7.3
246
2003
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.6
7.3
46
197
J30.0
ICD-10 Finland
Vasomotor rhinitis
5.9
7.2
19
34
A02BC02
ATC
pantoprazole; systemic
2.0
7.0
209
1607
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
7.0
120
767
A01AB04
ATC
amphotericin B; local oral
3.6
6.8
23
68
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.8
132
876
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
6.7
22
64
N03AX16
ATC
[U] pregabalin
2.1
6.6
80
450
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
6.6
85
490
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.8
6.4
32
121
J66.8
ICD-10 Finland
Airway disease due to other specific organic dusts
+∞
6.3
6
*
R2110
NOMESCO Finland
Giving the first information
3.1
6.2
27
94
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.6
6.1
38
161
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
6.1
42
187
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
6.0
23
74
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
182
1130
2.59
14.01
5.8
5.5
55.31
56.19
%
0.56
170
1069
183
1141
2.59
13.94
5.9
5.8
30.25
29.14
%
0.81
171
1083
81
339
2.92
13.86
2.9
2.6
1.70
2.93
e6/l
1.21
31
178
59
218
3.13
12.48
3.9
2.2
33.00
33.65
u/l
0.05
48
185
81
366
2.67
11.79
3.0
2.4
0.37
0.86
e6/l
2.67
32
203
198
1398
2.27
9.81
7.5
9.4
3.87
3.99
e9/l
0.34
167
1233
141
873
2.18
9.71
2.1
1.8
96.19
100.05
pmol/l
0.49
63
448
79
389
2.41
9.39
2.6
2.6
2.41
2.45
mmol/l
2.33
66
349
56
266
2.36
7.07
2.8
2.2
5.27
8.32
umol/l
1.03
44
231
71
381
2.14
6.67
5.3
3.4
267.53
285.86
ng/l
0.03
51
269
17
43
4.13
6.26
1.4
1.1
—
—
—
0
0
17
43
4.13
6.26
1.4
1.1
—
—
—
0
0
150
1079
1.79
5.70
3.2
2.6
85.68
89.04
ug/l
0.11
142
1006
117
787
1.81
5.53
3.4
3.1
2.37
2.36
mmol/l
0.04
104
709
252
2151
2.18
5.38
20.2
14.2
13.76
14.75
%
4.46
246
2123
213
1726
1.84
5.19
4.5
3.1
—
—
—
0
0
95
618
1.79
4.92
3.5
2.7
0.09
0.36
e6/l
2.14
56
457
132
946
1.72
4.85
3.7
4.1
37.10
36.54
g/l
0.65
125
897
84
532
1.81
4.73
2.2
1.6
1.17
0.94
mg/l
0.23
68
414
22
81
2.85
4.63
1.2
1.1
—
—
—
0
0
22
82
2.82
4.53
1.2
1.1
—
—
—
0
0
81
514
1.79
4.51
2.1
1.5
—
—
—
0
0
34
638
0.47
4.21
3.2
3.4
0.00
0.00
estimate
—
9
223
134
995
1.64
4.12
5.6
5.0
1.22
1.22
mmol/l
0.50
127
912
90
608
1.69
3.96
1.3
1.2
0.47
1.22
u/ml
1.60
12
180
91
617
1.69
3.95
2.6
2.6
6531.87
6100.68
umol/l
0.02
83
550
136
1022
1.61
3.93
2.5
2.2
75.11
76.58
nmol/l
0.23
124
924
19
71
2.79
3.90
1.7
1.1
—
—
—
0
0
50
289
1.88
3.72
2.1
1.9
29.21
29.23
s
0.01
50
282
218
1856
1.67
3.63
4.3
3.9
10.80
10.53
mm/h
0.11
201
1723
18
68
2.75
3.63
1.9
1.3
—
—
—
0
0
18
68
2.75
3.63
1.1
1.2
—
—
—
0
0
94
656
1.64
3.61
1.8
1.6
1.47
1.44
mmol/l
0.14
85
560
23
99
2.44
3.60
6.0
5.7
24.37
25.45
mmol/l
0.73
23
99
16
57
2.91
3.58
1.6
1.7
—
—
—
0
0
229
1979
1.70
3.56
4.3
4.0
14.28
14.57
pmol/l
0.99
220
1818
39
213
1.96
3.43
2.3
1.8
—
—
—
0
0
12
33
3.75
3.33
2.1
1.5
—
—
—
0
0
21
90
2.44
3.33
2.0
1.5
—
—
—
0
0
262
2368
1.95
3.32
14.4
10.7
86.17
84.58
ml/min/173m2
0.67
205
1938
20
84
2.48
3.30
1.8
1.9
—
—
—
0
0
109
811
1.55
3.12
3.3
2.8
—
—
—
0
0
140
1101
1.52
3.10
6.4
5.8
1.22
1.22
mmol/l
0.53
128
945
18
75
2.49
3.03
1.7
1.3
338.18
333.58
ug/g
0.04
11
42
214
1850
1.57
2.99
8.0
7.1
83.15
77.46
u/l
0.54
204
1736
37
209
1.88
2.95
2.4
1.7
—
—
—
0
0
6
10
6.10
2.71
1.0
1.0
—
—
—
0
0
73
513
1.56
2.64
1.5
1.3
13.07
34.51
iu/ml
3.62
19
188
9
25
3.68
2.59
1.0
1.2
—
—
—
0
0
9
25
3.68
2.59
1.0
1.2
—
—
—
0
0
69
481
1.57
2.58
1.5
1.4
20.92
22.36
nmol/l
0.42
62
407
268
2480
1.88
2.57
17.2
11.6
21.27
20.11
mg/l
0.25
209
1918
5
7
7.24
2.56
1.2
1.0
95.00
101.00
%
—
5
7
201
1741
1.48
2.55
3.0
2.9
46.31
43.91
u/l
0.14
187
1648
28
152
1.93
2.53
1.4
1.4
—
—
—
0
0
69
943
0.65
2.52
2.4
3.3
—
—
—
0
0
9
26
3.54
2.50
1.0
1.2
—
—
—
0
0
9
26
3.54
2.50
1.0
1.2
—
—
—
0
0
9
26
3.54
2.50
1.0
1.2
—
—
—
0
0
21
103
2.12
2.48
2.1
1.6
—
—
—
0
0
255
2334
1.68
2.44
5.6
4.7
1.57
2.39
mu/l
0.95
246
2155
17
78
2.25
2.36
1.2
2.6
1.70
1.45
g/l
0.28
11
68
34
208
1.72
2.12
1.1
1.2
62.33
154.32
iu/ml
1.71
11
91
5
10
5.06
2.08
1.2
2.5
—
—
—
0
0
5
10
5.06
2.08
1.2
2.5
—
—
—
0
0
11
44
2.56
2.03
1.8
1.4
—
—
—
0
0
6
16
3.80
1.94
1.3
1.6
—
—
—
0
0
6
16
3.80
1.94
1.8
1.5
4.67
2.83
mg/l
—
6
16
42
280
1.58
1.90
2.0
1.7
—
—
—
0
0
148
1254
1.36
1.87
5.8
5.8
10.75
10.07
umol/l
0.47
139
1190
68
506
1.45
1.85
1.5
1.3
2.51
11.36
u/ml
2.95
18
215
8
29
2.81
1.80
1.0
1.2
—
—
—
0
0
45
309
1.54
1.80
2.7
1.9
—
—
—
0
0
45
309
1.54
1.80
2.2
1.8
—
—
—
0
0
51
362
1.49
1.75
1.6
1.7
1032.13
1163.37
nmol/l
0.56
39
274
14
68
2.11
1.73
1.2
1.2
390.36
430.65
mg/l
0.33
14
63
72
550
1.41
1.69
2.3
2.1
—
—
—
0
0
28
174
1.67
1.68
3.8
3.4
1.19
2.36
mmol/l
1.12
22
148
24
143
1.74
1.67
1.2
1.3
23.24
30.33
iu/l
0.59
19
122
244
2266
1.44
1.59
5.2
5.2
38.01
39.10
mmol/mol
1.45
234
2130
27
169
1.66
1.58
2.6
2.4
66.22
67.93
g/l
0.53
22
156
7
27
2.63
1.52
1.3
1.1
—
—
—
0
0
21
124
1.75
1.52
2.2
1.5
—
—
—
0
0
6
21
2.89
1.51
1.0
1.0
—
—
—
0
0
6
22
2.76
1.44
3.7
3.8
—
—
—
0
0
33
223
1.54
1.44
1.9
4.1
2.60
7.19
ug/l
2.03
23
181
80
982
0.75
1.43
16.8
10.0
1.17
1.10
inr
0.25
14
288
34
232
1.53
1.42
5.5
5.6
104.59
104.18
mmol/l
0.21
34
232
23
144
1.65
1.37
1.1
1.0
—
—
—
0
0
18
290
0.60
1.32
5.4
5.6
—
—
—
0
0
6
25
2.43
1.25
1.0
1.0
—
—
—
0
0
6
25
2.43
1.25
1.0
1.1
—
—
—
0
0
24
156
1.59
1.24
2.8
1.6
—
—
—
0
0
9
45
2.03
1.24
1.3
1.3
—
—
—
0
0
8
37
2.19
1.22
1.4
1.3
—
—
—
0
0
5
19
2.66
1.22
1.0
1.0
—
—
—
0
0
0
34
0.00
1.16
0.0
1.6
—
—
—
0
0
0
36
0.00
1.14
0.0
2.9
—
55.49
—
0
36
253
2404
1.37
1.08
4.6
4.3
5.89
5.84
mmol/l
0.22
237
2233
6
125
0.47
1.07
6.3
3.6
1.37
1.61
mmol/l
—
6
92
33
241
1.42
1.02
3.0
2.5
0.67
0.70
ug/l
0.12
22
145
7
133
0.51
1.01
5.7
3.5
5.26
5.10
kpa
—
7
128
7
134
0.51
1.01
1.7
1.5
—
—
—
0
0
7
36
1.97
0.97
1.0
1.1
—
—
—
0
0
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
31
228
1.40
0.93
2.4
2.0
378.83
356.17
nmol/l
0.20
24
207
134
1196
1.22
0.93
4.6
4.5
0.00
0.00
estimate
—
9
224
6
30
2.02
0.87
1.0
1.0
—
—
—
0
0
272
2634
1.42
0.84
17.0
13.5
68.77
71.89
umol/l
2.09
272
2634
73
854
0.81
0.84
3.5
3.3
11.66
35.03
ng/l
2.82
31
536
6
32
1.89
0.82
1.0
1.0
—
—
—
0
0
10
58
1.75
0.80
1.8
1.5
—
—
—
0
0
10
58
1.75
0.80
1.8
1.5
—
—
—
0
0
10
58
1.75
0.80
1.8
1.5
—
—
—
0
0
10
58
1.75
0.80
1.8
1.5
—
—
—
0
0
8
48
1.68
0.79
1.9
1.1
—
—
—
0
0
61
509
1.25
0.79
2.2
2.0
3.25
3.06
mg/l
0.12
46
437
6
34
1.78
0.76
1.3
1.7
—
—
—
0
0
12
75
1.63
0.76
1.5
1.8
1.98
6.60
iu/l
—
5
22
133
1205
1.19
0.75
2.8
3.2
0.00
0.01
estimate
—
8
213
5
24
2.10
0.75
1.4
1.7
—
—
—
0
0
5
25
2.02
0.73
1.0
1.8
—
—
—
0
0
35
275
1.31
0.72
1.7
1.7
—
—
—
0
0
9
58
1.57
0.70
1.7
2.4
—
—
—
0
0
10
61
1.66
0.69
1.7
1.2
—
—
—
0
0
5
28
1.80
0.66
1.4
1.7
—
—
—
0
0
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
10
63
1.61
0.62
2.0
1.6
—
—
—
0
0
36
440
0.79
0.62
1.5
1.6
474.31
13405265.36
pmol/l
0.50
29
373
14
197
0.70
0.61
2.9
3.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.7
—
52.87
—
0
15
16
114
1.43
0.60
1.8
2.0
3.12
2.74
mg/l
0.14
11
87
10
64
1.58
0.59
1.1
1.3
—
42.36
—
0
7
272
2654
1.32
0.59
11.1
9.6
27.11
25.75
u/l
0.53
267
2567
6
35
1.73
0.58
2.0
1.7
—
—
—
0
0
283
2779
1.45
0.56
22.6
17.6
4.47
4.51
e12/l
0.90
277
2719
6
97
0.61
0.53
2.0
3.4
68.08
51.10
%
—
6
97
39
328
1.22
0.49
3.5
4.2
21.29
21.42
%
0.01
13
144
7
46
1.53
0.48
1.4
2.0
—
—
—
0
0
259
2523
1.22
0.48
4.9
4.7
2.98
2.89
mmol/l
0.76
248
2361
7
48
1.47
0.47
1.6
1.3
—
104.50
—
0
10
5
83
0.60
0.46
4.8
2.1
—
—
—
0
0
7
51
1.38
0.44
2.1
1.7
—
—
—
0
0
128
1195
1.13
0.43
2.9
3.2
0.00
0.00
estimate
—
9
235
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
37
1.36
0.37
1.4
1.2
—
—
—
0
0
20
163
1.24
0.35
2.1
1.5
—
—
—
0
0
62
562
1.13
0.34
2.4
2.9
591.56
724.04
ng/l
0.25
45
469
6
47
1.28
0.32
2.3
1.6
—
—
—
0
0
6
47
1.28
0.32
2.3
1.6
—
—
—
0
0
13
101
1.30
0.32
2.0
2.4
0.47
0.65
%
1.52
13
101
7
56
1.26
0.29
1.1
1.3
—
—
—
0
0
7
56
1.26
0.29
2.1
1.6
—
—
—
0
0
59
539
1.12
0.29
1.3
1.5
—
—
—
0
0
127
1332
0.92
0.28
5.1
3.9
6.28
6.54
mmol/l
0.86
119
1242
0
10
0.00
0.21
0.0
4.0
—
—
—
0
0
0
10
0.00
0.21
0.0
4.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
8.80
—
0
12
6
49
1.23
0.20
2.2
1.3
—
—
—
0
0
69
651
1.08
0.18
3.2
3.7
3.86
7.52
mg/mmol
0.91
40
389
7
60
1.17
0.18
1.0
1.2
—
—
—
0
0
18
198
0.90
0.11
1.9
2.6
86.30
69.94
ml/min/173m2
—
10
81
11
97
1.14
0.09
1.0
1.4
146.70
257.25
miu/ml
—
5
47
110
1125
0.96
0.08
2.7
2.3
—
—
—
0
0
8
76
1.05
0.07
1.1
1.3
—
2.39
—
0
14
250
2484
1.04
0.06
4.1
4.3
4.94
4.86
mmol/l
0.58
237
2337
11
118
0.93
0.03
1.3
1.4
—
—
—
0
0
12
113
1.06
0.02
1.4
1.5
—
—
—
0
0
238
2387
0.98
0.01
3.5
3.8
1.31
1.31
mmol/l
0.01
220
2229
10
99
1.01
0.00
1.0
1.7
—
—
—
0
0
11
105
1.05
0.00
1.9
1.5
—
—
—
0
0
247
2474
0.99
0.00
3.9
4.3
1.55
1.53
mmol/l
0.26
230
2314
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
59
0.84
-0.00
3.0
4.0
—
4.21
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PROBL_RELATED_PHYSIC_ENVIRONMENT – Problems related to physical environment
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).